I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Socinski, M.
~ 100
results:
Search for persons
X
Format
Online
Mediatypes
Articles (Online)
Bookchapter (Online)
OpenAccess-fulltext
Sorted by: Relevance
Sorted by: Year
?
1
A phase I study to evaluate the safety, pharmacokinetics, a..:
Rodon, J.
;
Rodriguez, E.
;
Maitland, M.L.
...
ESMO Open. 9 (2024) 4 - p. 102961 , 2024
Link:
https://doi.org/10.1016/..
?
2
Predictive biomarkers for response to EGFR-directed monoclo..:
Bonomi, P.D.
;
Gandara, D.
;
Hirsch, F.R.
...
Annals of Oncology. 29 (2018) 8 - p. 1701-1709 , 2018
Link:
https://doi.org/10.1093/..
?
3
Heart Dosimetric Analysis of Three Types of Cardiac Toxicit..:
Wang, K.
;
Pearlstein, K.A.
;
Patchett, N.D.
...
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S152 , 2017
Link:
https://doi.org/10.1016/..
?
4
Results of a Single-Institution Experience With Dose-Escala..:
Bernard, M.
;
Glaser, S.M.
;
Gill, B.S.
...
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E449 , 2016
Link:
https://doi.org/10.1016/..
?
5
The Effect of Necitumumab in Combination with Gemcitabine-C..:
Reck, M
;
Socinski, M
;
Szczesna, A
...
Value in Health. 19 (2016) 7 - p. A748-A749 , 2016
Link:
https://doi.org/10.1016/..
?
6
Correlation of EGFR-expression with safety and efficacy out..:
Paz-Ares, L.
;
Socinski, M.A.
;
Shahidi, J.
...
Annals of Oncology. 27 (2016) 8 - p. 1573-1579 , 2016
Link:
https://doi.org/10.1093/..
?
7
3109 nab-Paclitaxel (nab-P) plus carboplatin (C) as first-l..:
Gridelli, C.
;
Li, L.
;
O'Brien, M.
...
European Journal of Cancer. 51 (2015) - p. S638-S639 , 2015
Link:
https://doi.org/10.1016/..
?
8
3073 Exploratory analysis of frontline therapies in REVEL: ..:
Garon, E.B.
;
Scagliotti, G.V.
;
Gautschi, O.
...
European Journal of Cancer. 51 (2015) - p. S621 , 2015
Link:
https://doi.org/10.1016/..
?
9
3009 Activity of rociletinib in EGFR mutant NSCLC patients ..:
Varga, A.
;
Camidge, D.R.
;
Sequist, L.V.
...
European Journal of Cancer. 51 (2015) - p. S598 , 2015
Link:
https://doi.org/10.1016/..
?
10
Erlotinib in African Americans With Advanced Non–Small Cell..:
Phelps, M A
;
Stinchcombe, T E
;
Blachly, J S
...
Clinical Pharmacology & Therapeutics. 96 (2014) 2 - p. 182-191 , 2014
Link:
https://doi.org/10.1038/..
?
11
Update on Taxanes in the First-Line Treatment of Advanced N..:
Socinski, M.A.
Current Oncology. 21 (2014) 5 - p. 691-703 , 2014
Link:
https://doi.org/10.3747/..
?
12
41 Clinical activity of BIND-014 (docetaxel nanoparticles f..:
Natale, R.
;
Socinski, M.
;
Hart, L.
...
European Journal of Cancer. 50 (2014) - p. 19 , 2014
Link:
https://doi.org/10.1016/..
?
13
Analysis of Outcomes in Diabetic Patients in a Phase 3 Tria..:
Hirsh, V.
;
Owen, S.P.
;
Ko, A.
..
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S21 , 2014
Link:
https://doi.org/10.1016/..
?
14
Switch Maintenance With Sunitinib (S) in Advanced Non-Small..:
Socinski, M.A.
;
Wang, X.
;
Baggstrom, M.
...
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S1 , 2014
Link:
https://doi.org/10.1016/..
?
15
Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlot..:
Gerber, D.E.
;
Socinski, M.A.
;
Neal, J.W.
...
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S36 , 2014
Link:
https://doi.org/10.1016/..
1-15